Skip to content

Proposed pilot only: not funded and not running. Everything described here is planned for 2027–2028 in a simulated proposal. Learn more

Kushalam by MHEP

References

Every source cited on this site

APA 7th edition, grouped by type. Citations are kept in their original English.

Peer-reviewed studies

  • Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018). Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: Updated meta-analyses. BMJ, 363, k4823. https://doi.org/10.1136/bmj.k4823
  • Costa, S., Verberckmoes, B., Castle, P. E., & Arbyn, M. (2023). Offering HPV self-sampling kits: An updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening. British Journal of Cancer, 128, 805–813. https://doi.org/10.1038/s41416-022-02094-w
  • Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: The RE-AIM framework. American Journal of Public Health, 89(9), 1322–1327. https://doi.org/10.2105/AJPH.89.9.1322
  • Ilankoon, I. M. P. S., Goonewardena, C. S. E., Fernandopulle, R. C., & Perera, P. P. R. (2017). An insight to how estate women in Sri Lanka manage abnormal vaginal discharge. Iranian Journal of Public Health, 46(2), 268–269.
  • Mapitigama, N., Moonesinghe, L. N., Punchihewa, R., & Perera, C. (2023). A descriptive study of different methods of cervical cancer screening among ever-married women in 35-year and 45-year cohorts in Kalutara District, Sri Lanka. Asian Pacific Journal of Cancer Prevention, 24(5), 1487–1493. https://doi.org/10.31557/APJCP.2023.24.5.1487
  • Perera, K. C. M., Mapitigama, N., & Abeysena, H. T. C. S. (2021). The feasibility of new HPV/DNA test as a primary cervical cancer screening method among 35-years-old ever-married women in Kalutara district. BMC Public Health, 21, 131. https://doi.org/10.1186/s12889-021-10190-4
  • Perera, K. C. M., Mapitigama, K. N., & Abeysena, H. T. C. S. (2024). Prevalence of vaginal and cervical HPV infection among 35-year age cohort ever-married women in Kalutara district of Sri Lanka and the validity of vaginal HPV/DNA specimen as a cervical cancer screening tool. BMC Infectious Diseases, 24, 1249. https://doi.org/10.1186/s12879-024-10150-4
  • Scheirer, M. A., & Dearing, J. W. (2011). An agenda for research on the sustainability of public health programs. American Journal of Public Health, 101(11), 2059–2067. https://doi.org/10.2105/AJPH.2011.300193
  • Shelton, R. C., Cooper, B. R., & Stirman, S. W. (2018). The sustainability of evidence-based interventions and practices in public health and health care. Annual Review of Public Health, 39, 55–76. https://doi.org/10.1146/annurev-publhealth-040617-014731
  • Srinath, A., van Merode, F., Rao, S. V., & Pavlova, M. (2023). Barriers to cervical cancer and breast cancer screening uptake in low- and middle-income countries: A systematic review. Health Policy and Planning, 38(4), 509–527. https://doi.org/10.1093/heapol/czac104
  • Wu, J., Jin, Q., Zhang, Y., Ji, Y., Li, J., Liu, X., Duan, H., Feng, Z., Liu, Y., Zhang, Y., Lyu, Z., Yang, L., & Huang, Y. (2025). Global burden of cervical cancer: Current estimates, temporal trend and future projections based on the GLOBOCAN 2022. Journal of the National Cancer Center, 5(3), 322–329. https://doi.org/10.1016/j.jncc.2024.11.006
  • Yeh, P. T., Kennedy, C. E., de Vuyst, H., & Narasimhan, M. (2019). Self-sampling for human papillomavirus (HPV) testing: A systematic review and meta-analysis. BMJ Global Health, 4(3), e001351. https://doi.org/10.1136/bmjgh-2018-001351

World Health Organization and international agencies

Government and other reports